GSK
825 hedge funds and large institutions have $11.2B invested in GSK in 2020 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 247 increasing their positions, 336 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
10% less capital invested
Capital invested by funds: $12.4B → $11.2B (-$1.21B)
26% less repeat investments, than reductions
Existing positions increased: 247 | Existing positions reduced: 336
Holders
825
Holding in Top 10
11
Calls
$81.6M
Puts
$67.4M
Top Buyers
| 1 | +$131M | |
| 2 | +$45.5M | |
| 3 | +$26.3M | |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$26M |
| 5 |
D.E. Shaw & Co
New York
|
+$24.3M |
Top Sellers
| 1 | -$96M | |
| 2 | -$87.4M | |
| 3 | -$83.6M | |
| 4 |
Two Sigma Investments
New York
|
-$51.9M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$45.3M |